Background Juvenile nasopharyngeal angiofibromas are one of the most enigmatic, bloody
tumors encountered by otorhinolarygnologists, head and neck surgeons, neurosurgeons …

Patient blood management is a patient‐centered evidence‐based approach to improve
patient outcomes by harnessing the patient's own hematopoietic system to optimize blood …

Patient blood management (PBM) encompasses implementing multimodal evidence-based
strategies to screen, diagnose, and properly treat anaemia and coagulopathies using goal …

Background Antifibrinolytic medications have been associated with reduced mortality in
pediatric hemorrhage but may contribute to adverse events such as acute kidney injury …

The field of pediatric neuroanesthesia has evolved with concurrent changes in pediatric
neurosurgical practice. Ongoing pediatric neuroanesthesia investigations provide novel …

Craniofacial anomalies involve patients of all ages and include a wide range of disorders.
Anesthetic plans are individualized to the patient, their underlying comorbidities, and the …

Purpose Despite the widespread use of tranexamic acid (TXA) in plastic surgery, guidelines
for the safe and effective administration have yet to be established. The present study …

Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is
recommended for major pediatric surgery to decrease perioperative blood loss …

Background: Although many published studies have investigated the benefits of tranexamic
acid (TXA) in reducing perioperative bleeding, no large meta-analysis has been conducted …

Background Ε‐Aminocaproic acid oral solution (EACA OS) is the only commercially
available antifibrinolytic for patients who cannot swallow tablets. Insurance denials and high …